# Butterfly Network, Inc. (BFLY) Stock Analysis: 40% Potential Upside with Cutting-Edge Medical Devices

- Link: https://www.directorstalkinterviews.com/butterfly-network-inc-bfly-stock-analysis-40-potential-upside-with-cutting-edge-medical-devices/4121245616
- Published: 2026-03-20T11:28:37+00:00
- Author: Madison Wilson

For investors keen on the healthcare sector, Butterfly Network, Inc. (NASDAQ: BFLY)
offers an intriguing opportunity with notable potential upside. This medical device
company is at the forefront of ultrasound imaging solutions, providing innovative
products such as the Butterfly iQ+ and iQ3 systems, which have revolutionized whole-
body imaging with their portability and integration with smartphones and tablets.

Currently trading at $3.97, Butterfly Network’s stock has experienced a slight price
increase of 0.01% recently, with a 52-week range between $1.33 and $4.95. While 
the company currently does not have a trailing P/E ratio due to negative earnings,
its forward P/E stands at -39.70, reflecting the challenges and growth investments
typical of an emerging tech-driven company in the healthcare space.

Financially, Butterfly Network boasts a market capitalization of $1.01 billion, 
underpinned by a remarkable revenue growth rate of 41%. However, investors should
be aware of the company’s negative EPS of -0.31 and a return on equity of -42.25%,
indicating that while the company is expanding its revenue base, it has yet to achieve
profitability. The free cash flow of $12.7 million is a positive indicator, suggesting
operational efficiencies and cash management strategies are in place.

From an analyst perspective, Butterfly Network is viewed favorably, with five buy
ratings and no hold or sell ratings. The consensus among analysts suggests a target
price range between $5.25 and $6.00, presenting a significant potential upside of
approximately 40.11% from current levels. This optimism is driven by the company’s
robust product portfolio and strategic positioning in the medical imaging market.

Technical indicators provide further insights into the stock’s trajectory. The 50-
day moving average is $3.83, while the 200-day moving average stands at $2.64, indicating
a strong upward trend over the past months. The Relative Strength Index (RSI) of
38.27 suggests the stock is nearing oversold territory, potentially setting the 
stage for a rebound. Additionally, the MACD of 0.10 and a signal line of 0.06 further
support a bullish outlook in the near term.

Despite the absence of a dividend yield, Butterfly Network’s focus on reinvesting
in growth and innovation presents a compelling case for investors looking for long-
term value creation. The company’s strategic initiatives, such as the Compass AI
system and ScanLab educational platform, position it as a leader in the integration
of AI with medical imaging technology, enhancing its competitive edge.

Founded in 2011 and headquartered in Burlington, Massachusetts, Butterfly Network
continues to expand its reach both domestically and internationally, leveraging 
direct sales, distributors, and e-commerce channels. As the healthcare industry 
increasingly shifts toward portable and integrated solutions, Butterfly Network’s
cutting-edge technology and visionary approach could offer substantial returns for
investors willing to ride out the near-term volatility.

Share on: